Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Glycerol parenteral preparations

Thus, an increase in viscosity, leading to a reduced quenching rate constant (Equation 14.8), will result in an increased lifetime of the reactive intermediate (Equation 14.9). Depending on the nature of the diffusion-controlled reaction and the reactivity of the products formed, a rise in viscosity by addition of cosolvents like glycerol to the parenteral preparation can lead to improved or reduced photochemical... [Pg.312]

A. Parenteral. Propofol (Diprivan) 1% (10 mg/mL) emulsion in 10% soybean oil with 2.25% glycerol and 1.25% purified egg phospholipid in 20-, 50-, or 100-mL vials and a 50-mL prefilled syringe. Contains disodium EDTA or sodium metabisulfite in the US formulation as preservatives. A 2% (20 mg/mL) emulsion has been formulated to provide the same amount of drug with less lipid concentration, but is not yet approved in the United States. Note Propofol is provided as a ready-to-use preparation, but if dilution is necessary, only use D5W and don t dilute to conoentrations less than 2 mg/mL. [Pg.496]


See other pages where Glycerol parenteral preparations is mentioned: [Pg.170]    [Pg.3955]    [Pg.78]    [Pg.310]    [Pg.397]    [Pg.297]    [Pg.292]    [Pg.87]    [Pg.265]    [Pg.512]    [Pg.526]    [Pg.641]    [Pg.240]   
See also in sourсe #XX -- [ Pg.272 , Pg.273 ]




SEARCH



Parenteral preparation

© 2024 chempedia.info